Safety and Feasibility of ≤24‐h Short‐Stay Right Colectomies for Primary Colon Cancer

Abstract

AbstractBackgroundHospital length of stay (LOS) has been used as a surgical quality metric. This study seeks to determine the safety and feasibility of right colectomy as a ≤24‐h short‐stay procedure for colon cancer patients.MethodsThis was a retrospective cohort study using the ACS‐NSQIP database and its Procedure Targeted Colectomy database (2012–2020). Adult patients with colon cancer who underwent right colectomies were identified. Patients were categorized into LOS  ≤1 day (≤24‐h short‐stay), LOS 2–4 days, LOS 5–6 days, and LOS ≥7 days groups. Primary outcomes were 30‐day overall and serious morbidity. Secondary outcomes were 30‐day mortality, readmission, and anastomotic leak. The association between LOS and overall and serious morbidity was assessed using multivariable logistic regression.Results19,401 adult patients were identified, with 371 patients (1.9%) undergoing short‐stay right colectomies. Patients undergoing short‐stay surgery were generally younger with fewer comorbidities. Overall morbidity for the short‐stay group was 6.5%, compared to 11.3%, 23.4%, and 42.0% for LOS 2–4 days, LOS 5–6 days, and LOS ≥7 days groups, respectively (p < 0.001). There were no differences in anastomotic leak, mortality, and readmission rates in the short‐stay group compared to patients with LOS 2–4 days. Patients with LOS 2–4 days had increased odds of overall morbidity (OR 1.71, 95% CI 1.10–2.65, p = 0.016) compared to patients with short‐stay but no differences in odds of serious morbidity (OR 1.20, 95% CI 0.61–2.36, p = 0.590).Conclusions ≤24‐h short‐stay right colectomy is safe and feasible for a highly‐select group of colon cancer patients. Optimizing patients preoperatively and implementing targeted readmission prevention strategies may aid patient selection.